Hepatitis C virus infection does not prevent autologous bone marrow transplantation in HIV-related non-Hodgkin's Lymphoma [3]

AIDS

Volumn 18, Issue 13, 2004, Pages 1859-1861

  Simonelli, Cecilia ^a   Michieli, Mariagrazia ^a   Tedeschi, Rosamaria ^a   Rupolo, Maurizio ^a   Abbruzzese, Luciano ^a   Sartor, Ivana ^a   Gattei, Valter ^a   Spina, Michele ^a   De Paoli, Paolo ^a   Tirelli, Umberto ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMINOTRANSFERASE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BLEOMYCIN; CARMUSTINE; CD4 ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EFAVIRENZ; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; LAMIVUDINE PLUS ZIDOVUDINE; MELPHALAN; METHOTREXATE; PREDNISONE; PYRROLE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AMINOTRANSFERASE BLOOD LEVEL; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CASE REPORT; CELL COUNT; DISEASE ACTIVITY; DRUG MEGADOSE; DRUG RESPONSE; EXTRAHEMATOLOGICAL TOXICITY; FEVER; GRANULOCYTE; HEPATITIS C; HEPATITIS C VIRUS; HERPES SIMPLEX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LETTER; LIVER FUNCTION; LIVER TOXICITY; MALE; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROPHYLAXIS; REMISSION; SIDE EFFECT; THROMBOCYTE; TOXICITY;

ADULT; BONE MARROW TRANSPLANTATION; HEPATITIS C; HIV INFECTIONS; HUMANS; LYMPHOMA, NON-HODGKIN;

EID: 4444252244     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200409030-00021     Document Type: Letter

References (18)

1. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333:1890-1900.
2. Linch DC, Winfield D, Goldstone AH, Moir D, Hancock B, McMillan A, et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 1993; 341:1051-1054.
3. Flexner C. HIV protease inhibitors. N Engl J Med 1998; 338:1281-1292.
4. Tirelli U, Errante D, Spina M, Gastaldi R, Nigra E, Nosari AM, et al. Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients. Cancer 1996; 77:2127-2131.
5. Levine AM, Tulpule A, Tessman D, Kaplan L, Giles F, Luskey BD, et al. Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial. J Clin Oncol 1997; 15:1094-1103.
6. Spina M, Vaccher E, Juzbasic S, Milan I, Nasti G, Talamini R, et al. Human immunodeficiency virus-related non-Hodgkin lymphoma: activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients. Cancer 2001; 92:200-206.
7. Bi J, Espina BM, Tulpule A, Boswell W, Levine AM. High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma. J Acquired Immune Defic Syndr 2001; 28:416-421.
8. Gabarre J, Azar N, Autran B, Katlama C, Leblond V. High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma. Lancet 2000; 355:1071-1072.
9. Krishnan A, Molina A, Zaia J, Nademanee A, Kogut N, Rosenthal J, et al. Autologous stem cell transplantation for HIV-associated lymphoma. Blood 2001; 98:3857-3859.
10. Re A, Cattaneo C, Michieli M, Casari S, Spina M, Rupolo M, et al. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 2003; 21:4423-4427.
11. Sperotto A, Silvestri F, Fanin R, Damiani D, Geromin A, Cerno M, et al. Feasibility of autologous stem cell transplantation in chronic carriers of hepatitis B and hepatitis C virus. Leuk Lymphoma 2000; 36:323-330.
12. Locasciulli A, Bruno B, Alessandrino EP, Meloni G, Arcese W, Bandini G, et al. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation. Bone Marrow Transplant2003; 31:295-300.
13. Sora F, Antinori A, Piccirillo N, De Luca A, Chiusolo P, Cingolani A, et al. Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia. Exp Hematol 2002; 30:279-284.
14. Spina M, Sparano JA, Jaeger U, Rossi G. Tirelli U. Rituximab and chemotherapy is highly effective in patients CD20-positive non-Hodgkin's lymphoma and HIV infection [Letter]. AIDS 2003; 17:2006-2007.
15. Klimo P, Connors JM. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med 1985; 102:596-602.
16. Mohsen AH, Easterbrook PJ, Taylor C, Portmann B, Kulasegaram R, Murad S, et al. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 2003; 52:1035-1040.
17. Tedaldi EM, Baker RK, Moorman AC, Alzola CF, Furhrer J, McCabe RE, et al. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2003; 36:363-367.
18. Sulkowsky MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Intern Med 2003; 138:197-207.